| 查看: 1087 | 回复: 2 | |||
[交流]
【求助】氧化型谷胱甘肽二钠注射液的原研商信息或其他文献均可
|
|
求助:氧化型谷胱甘肽二钠注射液由俄罗斯 Pharma BAM公司生产。 英文名称:Glutatione oxidized disodium salt 的相关文献及资料。万分感谢各位。 |
» 猜你喜欢
纳米传感器监测农药残留的疑惑
已经有0人回复
谁有人卫版 《毒理学基础》第七版书籍
已经有0人回复
药物学论文润色/翻译怎么收费?
已经有80人回复
[求助] 流式死活染 & 单细胞门控设置被质疑,如何优化并解释?
已经有1人回复
蛋白稳定性实验与功能实验不一致
已经有11人回复
第4年了,马上40了,可能我与国基确实无缘吧。。。
已经有12人回复
26有没有老师想收做定量药理的学生啊
已经有3人回复
2026年申博药学专业
已经有1人回复
26考博申请 学or专
已经有15人回复
小分子化学药物研究中PDE怎么查,有无相应网站推荐?
已经有0人回复
他汀类药物对HMG-COA还原酶抑制研究
已经有0人回复
» 抢金币啦!回帖就可以得到:
nanomaterials特刊:纳米材料在电化学能源领域的应用(SCI 中科院三区,IF4.5)征稿
+5/300
上海87年GG诚求女友
+1/169
海南大学专任教师招聘:海洋工程与海洋智能装备相关方向【长期有效】
+2/112
广东工业大学自动化学院鲁仁全教授团队刘勇华老师招收2026年博士研究生(申请制)
+1/84
南京林业大学特聘教授招聘博后和博士研究生
+1/82
深圳大学张雷教授课题组诚聘博士后
+1/75
华南理工大学(985、广州) 氢能源技术课题组诚招博士后(不限专业)
+1/53
电子科技大学崔春华课题组招收物理化学背景博士生1名-申请考核制
+2/46
[长期合作招募] 同济大学肖倩老师团队诚邀港澳学者学术交流
+1/34
华中科技大学周英教授招博后
+1/29
专科起点双非硕士,申博求建议
+1/20
2026申博自荐 本硕双一流学科 纳米药物递送方向 一篇一区TOP 两个国家奖学金
+1/17
【青岛大学】2026年生物医药博士生招生(含少数民族骨干人才)
+1/15
中国科学院深圳先进技术研究院合成生物学研究所陈禹课题组招聘博士后
+2/14
华南理工大学宋波教授招收2026年博士生(二氧化碳有机、高分子和光电生物催化还原)
+1/6
华南理工大学宋波教授招收2026年博士生(二氧化碳转化方向优先)
+1/6
复旦大学2026年博士研究生,“药学 + 合成生物学”
+1/4
华南理工大学宋波教授招收2026年博士生
+1/4
多伦多城市大学计算机视觉方向博士后
+1/1
南方科技大学田雷蕾课题组招收2026年博士生
+1/1
★
koria0727(金币+1):多谢参与。 2010-12-17 09:18:13
hypharm(金币+5): 2010-12-19 14:48:19
koria0727(金币+1):多谢参与。 2010-12-17 09:18:13
hypharm(金币+5): 2010-12-19 14:48:19
|
1题目Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells. Authors:du ZX; Zhang HY; Meng X; Guan Y; Wang HQ Abstract: BACKGROUND: The proteasome inhibitor bortezomib has shown impressive clinical activity alone and in combination with conventional and other novel agents for the treatment of multiple myeloma (MM) and some solid cancers. Although bortezomib is known to be a selective proteasome inhibitor, the downstream mechanisms of cytotoxicity and drug resistance are poorly understood. METHODS: Proteasome activity, intracellular glutathione (GSH) and ROS levels, as well as activities of GSH synthesis enzymes were measured using spectrophotometric methods. Cell death was analyzed using flow cytometry and caspase activity assay. The expression level of GSH synthesis enzymes were measured using real-time RT-PCR. RESULTS: At concentrations that effectively inhibited proteasome activity, bortezomib induced apoptosis in FRO cells, but not in ARO cells. Bortezomib elevated the amount of glutathione (GSH) and the treatment with bortezomib increased the level of mRNA for GCL, a rate-limiting enzyme in glutathione synthesis. Furthermore, depletion of GSH increases apoptosis induced by bortezomib, in contrast, repletion of GSH decreases bortezomib-mediated cell death. CONCLUSION: GSH protects cells from proteasome inhibition-induced oxidative stress and glutathione-dependent redox system might play an important role in the sensitivity to proteasome inhibition-induced apoptosis. Source:BMC Cancer [BMC Cancer] 2009; Vol. 9, pp. 56. Date of Electronic Publication: 2009 Feb 16 2Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)]. Authors:Galle J; Winner B; Conzelmann E; Wanner C Source:Cellular And Molecular Biology (Noisy-Le-Grand, France) [Cell Mol Biol (Noisy-le-grand)] 1998 Nov; Vol. 44 (7), pp. 1035-45. Abstract:diabetic patients develop endothelial dysfunction early in the course of the disease. Atherogenic lipoproteins such as LDL and Lp(a) are important risk factors for endothelial dysfunction and undergo nonenzymatic glycation in hyperglycaemia. Here we assessed whether glycation of Lp(a) potentiates its damaging influence on endothelial function. Human Lp(a) was glycated by dialyzation for 7 days against buffer containing 200 mmol/l glucose, or sham-treated without glucose and oxidized by incubation with Cu++. The degree of glycation accounted to 32 +/- 4%, and glycation rendered Lp(a) more susceptible to oxidative modification when exposed to Cu++. Isolated rings of rabbit aorta were superfused with physiological salt solution, and isometric tension was recorded. Incubation of the aortic rings with sham-treated or with 30 microg/ml glycated Lp(a), not oxidized, had no influence on acetylcholine-induced, endothelium-dependent relaxation. Exposure of the aortic rings to 30 microg/ml oxidized non-glycated (ox) Lp(a) caused a significant inhibition (19% at 1 microM acetylcholine) of the endothelium-dependent relaxation. Incubation of aortic rings with 30 microg/ml oxidized glycated (glyc-ox) Lp(a) attenuated endothelium-dependent relaxation more potently than oxLp(a) (by 34% at 1 microM acetylcholine). The presence of diethyl-dithio-carbamate (DDC), an inhibitor of the endogenous superoxide dismutase (SOD), potentiated the inhibition of relaxation induced by oxLp(a) and by glyc-oxLp(a) [38% inhibition at 1 microM acetylcholine for oxLp(a), and 49% inhibition at 1 microM acetylcholine for glyc-oxLp(a)]. Co-incubation with the O2- scavenger 4,5-dihydroxy-1,3-benzene disulfonic acid disodium salt (TIRON) prevented the inhibition of relaxation by the oxidized lipoproteins, suggesting that enhanced NO-inactivation by O2- could be the underlying mechanism for the impairment of endothelium-dependent dilations by ox- and glyc-oxLp(a). The concentration of lysophosphatidycholine, a lipoprotein oxidation product and stimulus for O2- formation, was significantly enhanced in oxLp(a) and in glyc-oxLp(a) compared to native lipoproteins. Conclusion: Glycation enhances the endothelium-damaging influence of oxLp(a), presumably by enhancing oxidative stress. The likely mechanism for attenuation of endothelium-dependent dilations is increased formation of O2-, resulting in inactivation of nitric oxide. This mechanism may play an important role in diabetic patients and may contribute to disturbed organ perfusion. [ Last edited by ronalbeck on 2010-12-16 at 14:45 ] |
2楼2010-12-16 14:43:58
3楼2010-12-19 14:47:59













回复此楼